Home » Committee of the Whole » Page 9

From Committee of the Whole

Resolution L6. (Wednesday Morning) Improving data collection on, and responses to, harmful effects of non-medical use of pharmaceuticals

Chair: L4 was agreed last night and submitted to the Plenary. We now discuss L6. Nigeria: I am glad to announce Angola also joined the cosponsors. In the second reading, we were able to agreed on 14 paragraphs including the title. We appreciate the cooperation and good spirits and flexibility demonstrated by colleagues. Chair: The …

Read more

Resolution L4 (Afternoon Session): Promoting alternative development as a development-oriented drug control strategy for building back better from the COVID-19 pandemic

Title Peru: We had a 4th informal meeting and have updates. The first point is the title of the draft resolution. Chair: Agreed. PP4 Peru: Next point is PP4. After informal discussions, we received an additional proposal which has lead to addition of PP4 alt 2 and PP4 alt 2bis. Both of these paragraphs stem from original draft. …

Read more

Committee of the Whole (Afternoon session) Resolution L.5: Promoting quality, affordable, scientific evidence-based and comprehensive drug prevention and treatment services

Chair: We will continue considerations of L5. Colleague from Portugal, could you inform us of progress in informals? (…) I’m informed that Portugal is not with us at the moment. That is the problem of not being in the same room. Perhaps colleagues from Peru? Also not in the room. I have to make a …

Read more

Resolution L.3 (Tuesday Morning Session): Ensuring access to drug treatment, education, after-care, rehabilitation, and social reintegration services, for people within marginalized populations

Chair: Welcome back. Ramadan began this morning for many people so Ramadan Mubarak. We have the schedule on the screen. Secretariat: To co-sponsor a draft resolution, MS should send a note verbal to the Secretariat until Friday noon. We ask all delegations to produce a good sound quality so we can assure interpretation. Chair: I …

Read more

Resolution L.6 (Afternoon Session): Improving data collection on, and responses to, harmful effects of non-medical use of pharmaceuticals

Introduction Nigeria: We will discuss from PP5 to OPs. We think what is important is to plan ahead and plan for tomorrow at 9 AM. At first, we thought there was opposition from other delegates, but now realize they were addressing a gap. Addressing this gap will allow law enforcement to improve data collection. Chair: We will …

Read more

Resolution L.4 (Afternoon Session): Promoting alternative development as a development-oriented drug control strategy for building back better from the COVID-19 pandemic

PP1 Peru: We have had 3 informal consults about this resolution. We have revised the proposed text which has allow us to move forward and achieve consensus among states. First part of text is the title. Delegations have expressed interest in this as final part of negotiations. Chair: Title will be discussed at the end. There …

Read more